Winner Profile
Bangliang Li
CEO, Huadong Medicine
Industry: Health Care Distributors
Company size: X-Large
Published: 2017-12-08
Is Huadong Medicine a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Bangliang Li (Huadong Medicine) earned the following Obermatt pins for the management performance.
Obermatt accolades Bangliang Li
| Year | Pin | Category |
|---|---|---|
| 2017 |  |
Growth Performance |
|
Operating Performance | |
|
Combined Performance |
Bangliang Li was included in the competition among China Top 100 Growth Companies (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Bangliang Li
In summary, Bangliang Li obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 54 in Combined Performance indicates that Bangliang Li was better than 54% of all other CEOs that were analyzed as part of the China Top 100 Growth Companies – China for one participation in Obermatt CEO competitions. Bangliang Li’s average ranking can be found in the Multi-Year Rankings for China Top 100 Growth Companies - China.